Experts claim that some Indian drug manufacturers cut corners and make substandard drugs for markets with non … tuberculosis drug samples that claim to be made in India and were sold in Africa, India, and five mid-income non-African countries … in India or non-African countries. Since this finding is robust for manufacturer-drug fixed effects, one likely …

Experts claim that some Indian drug manufacturers cut corners and make substandard drugs for markets with non … tuberculosis drug samples that claim to be made in India and were sold in Africa, India, and five mid-income non-African countries … in India or non-African countries. Since this finding is robust for manufacturer-drug fixed effects, one likely …

investments, of the IT firms in India. In particular, the paper examines the role of technology sourcing, both internal (in …-house R&D) and external (technology imports), in determining inter-firm variation in internationalisation. …

We empirically assess the determinants of India’s FDI outflows across a large sample of host countries in the 1996 … include: India’s outward FDI is hardly affected by motives to access raw materials or superior technologies. Market …-related factors appear to have dominated the location choices of Indian direct investors. A larger Indian diaspora in the host …

growth. To examine Indian imports from ASEAN, we utilize the ARDL bounds test for 2011-12 Q1 to 2020-21 Q2. The results …-run coefficient of export logs suggests a favourable impact on Indian imports from ASEAN, while the negative COVID-19 dummy … reject the null hypothesis of no level relationship between ASEAN imports and other variables. Notably, the positive long …